Applications Published 27 September 2000

Published: 26-Mar-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Geneticall engineered duckweed
    North Carolina State University 1037523*

  • Membrane virus host range mutations and their use as vaccine substrates
    Research Development Foundation 1037603*

  • Pharmaceutical aerosol compsns
    Minnesota Mining and Manufacturing 1037604*

  • Local delivery of therapeutic agents
    Supergen 1037605*

  • Preparation with a prolonged retention time at the site of application
    Bodmeiser, Roland 1037606*

  • Novel suppository form comprising an acid-labile active compound
    Byk Gulden Lomberg 1037607*

  • Acoustically activated localised drug delivery
    University of Utah Research Foundation; Brigham Young University 1037608*

  • Aqueous insecticidal pour-on formulation
    Schering-Plough Animal Health 1037609*

  • Liposomal camptothecin formulations
    NaXstar Pharmaceuticals 1037610*

  • Biodegradable mixed polymeric micells for gene delivery
    Samyang Corp 1037611*

  • Pharmaceutical compsns containing micronised bicyclic drugs
    SmithKline Beecham 1037612*

  • Method and device for producing pharmaceutical formulations containing an extract
    Janssen Pharmaceutica 1037613*

  • A double capsule for the administration of active principles in multiple therapies
    Axcan Pharma 1037614*

  • Compsns and methods fopr tratement of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
    Noven Pharmaceuticals 1037615*

  • Combination of alpha-adrenergic blockers and CGMP levels-elevating compounds effective for the treatment of impotence
    Pfizer Products 1037616*

  • Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease
    Novartis 1037617*

  • Use of nucelosides, nucelobases and their derivatives for reducing the thrombocytopenic side effects of cytostatic agents
    Max-Delbruck-Centrum fur Molekulare Medizin 1037618*

  • Selected C10 perfluoroinated hydrocarbons for liquid ventilation and artifical blood
    Synthetic blood international 1037619*

  • Use of formoterol in medicament for inflammation/allergy in upper airways
    AstraZeneca 1037620*

  • Nitric oxide donor compsns, methods, appartus and kits for preventing or allieviating vasocstriction of vasospasm in a mammal
    Thomas Jefferson University 1037621*

  • Taurine derivatives usable in the treatment of ophthalmic disorders
    Karageozian, Hampar 1037622*

  • Antuhyperlipidemic statin-LP(A) inhibitor combinations
    Warner-Lambert 1037623*

  • Methods and compsns for treating diabetes
    Purdue Research Foundation 1037624*

  • Process for producing arsenic tioxide formulations and methods for treating cancer using arsenic trioxide or melasoprol
    Memorial Sloan-Kettering Cancer Center 1037625*

  • Multicatalytic protase inhibitors for use as anti-tumour agents
    Cephalon 1037626*

  • Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[B,E]oxepin-2-acetic acid and of pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment of non-allergenic ophthalmic inflammatory disorders and for the prevention of ocular neovacularisation
    Alcon Laboratories 1037627*

  • Methods for preventing restenosis using tocotrienols
    Lipogenics Inc 1037628*

  • Combination of a retinoic acid metabolsim blocking agent and a tocophereol
    Janssen Pharmaceutica 1037629*

  • Method for the treatment of disorders associated with apoptosis using N-heterocyclic glyoxylamide compounds
    Shionogi & Co 1037630*

  • Heterocyclic cationic lipids
    Valentis 1037631*

  • Benzothiazole protein tyrosine kinase compounds
    Bristol-Myers Squibb 1037632*

  • Antiviral compounds
    Biochem Pharma 1037636*

  • Novel administration form comprising an acid-labile active compounds
    Byk Gulden Lomberg Chemische Fabrik 1037634*

  • Compounds and methods
    SmithKline Beecham 1037635*

  • Inhibition of membrane-associated viral replication
    The Chencellor, Masters and Scholars of the University of Oxford 1037636*

  • Use of 5HT1 receptor antagonists for preventing and/or treating temporal lobe epilepsy
    Princeton University 1037637*

  • Agents
    Lundblad, Leif 1037638*

  • Compounds of heteroaryl substituted imidazole, their pharmaceutical compsn and uses
    SmithKline Beecham 1037639*

  • Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
    The Regents of the University of Michigan 1037640*

  • Transcription factor decoy and tumour growth inhibitor
    The Government of the University States of America as represented by the Secretary, Department of Health and Human Services 1037641*

  • Modified polysaccharides exhibiting altered biological recognition
    Biomedical Frontiers 1037642*

  • Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
    Mayer Pharmaceuticals 1037643*

  • Compsns and methods for weight reduction
    Hessel, Lasse 1037644*

  • Process for making North American ginseng fractions, products containing them, and use as immunomodulators
    CV Technologies 1037645*

  • Ginko Biloba leaf extracts with a reduced 4'-O-methylpyridoxine and biflavone content
    Dr Milmar Schwabe 1037646*

  • Medicinal plant dry extracts
    Krewel Meuselback 1037647*

  • Use fo erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases
    Roche Diagnostics 1037648*

  • Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
    Enzon 1037649*

  • Methods and compsns for the treatment and prevention of Staphylococcus aureus infections
    Panorama Research 1037650*

  • Small peptides and methods for treatment of asthma and inflammation
    Hisatatek 1037651*

  • Pharmaceutical compsns based on dalforpristin and quinupristin and preparation
    Aventis Pharma 1037652*

  • Compsns and methods for regualting phagocytosis and ICAM-1 expression
    Johnson & Johnson Consumer Companies 1037653*

  • RIBA
    SmithKline Beecham 1037654*

  • Methods of treatment using novel ligands of the neuropeptide receptor HFGAN73 and agonists or antagonists thereof
    SmithKline Beecham 1037655*

  • Lymphtactin as an adjuvant
    The UAB Research Foundation 1037656*

  • Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same
    Enzon 1037657*

  • Fibrinogen inhibition for sealant
    Bristol-Myers Squibb 1037659*

  • RIBB
    SmithKline Beecham 1037660*

  • RIBH
    SmithKline Beecham 1037661*

  • Method to enahnce an immune response to nucleic acid vaccination
    SmithKline Beecham 1037662*

  • Methods to treat undesirable immune responses
    Regents of the University of California 1037663*

  • Vaccines containing attenuated bacteria
    Medeva Europe 1037664*

  • Methods and compsns for inhibiting tumour cell growth
    Beth Israel Deaconess Medical Centre 1037665*

  • Method for enhancing the absorption and transport lipid soluble compounds using structured glycerides
    Abbott Laboratories 1037666*

  • Pharmaceutical hydrogel formulatons, drug delivery devices and methods
    Alza Corp 1037667*

  • Transfection particles
    Boehringer Ingelheim 1037668*

  • Therapeutic uses of lentiviral vectors
    Naldini, Luigi; Song, Jin-Ping 1037669*

  • Agent for gene therapy of tumour, neurodegenerative, cardiovascular and automimmune diseases
    Max-Delbruck-Centrum fur Molekulare Medizin 1037670*

  • Polyrotaxanes
    Schering 1037671*

  • Dendritic polymer-saccharide conjugate, pharmaceuticals containing them said conjugates, method for its production and use thereof
    Schering 1037672*

  • Charged lipds and uses for the same
    Imarx Pharmaceuticals 1037673*

  • Container for timed release of substances
    Synoptik 1037674*

  • 1-(Adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
    Vernalis Research 1037874*

  • Method for producing salts of cyclic amidines
    Degussa-Huls 1037875*

  • Biphenyl derivatives as pharmaceuticals
    Novartis 1037876*

  • Acylated 4-aminopyridines as pesticides and fungicides
    Bayer 1037877*

  • Metabotropic glutamate receptor antagonists for treating central nervous system diseases
    NPS Pharmaceuticals 1037878*

  • Condensed pyridine derivatives
    Bayer 1037879*

  • Retinoic acid mimetic anilides
    Janssen Pharmaceutica 1037880*

  • Process of preparing substituted pyrimidinones
    Amgen 1037881*

  • Substituted 2,4-diamino-1,3,5-triazines
    Bayer; Nihon Bayer Agrochem 1037882*

  • Novel heterocyclic substituted $G(A)hydroxycarboxylic acid derivatives, method for producing the same and their use as andothelin receptor antagonists
    BASF 1037883*

  • Method for separating contaminants from 3-(2'-acetoxy-ethyl-dihydro-2(3H)furnanone
    BASF 1037884*

  • Novel water soluble photochromic compounds
    Transitions Optical 1037885*

  • Triazine angiogenesis inhibitors
    Abbott Laboratories 1037886*

  • ((E))-3-1-(N)-butyl-5-2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1$I(H)-pyrazol-4-yl]-2-(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid monoargininyl salt
    SmithKline Beecham 1037888*

  • Novel compounds
    AstraZeneca 1037889*

  • Amino-benzothiazole derivatives
    Pharmacia & Upjohn 1037890*

  • Method for preparing mequitazine and novel synehtsis intermediate
    Pierre Fabre Medicament 1037891*

  • Piperidine derivatives
    F Hoffmann-La Roche 1037892*

  • Use of nitroethane derivatives as microbicides and specific nitroethane derivatives
    BASF 1037893*

  • Preparation of alkylmonohydrogenohalogenosilanes by redistribution followed by distillation and associated device
    Rhodia Chemie 1037895*

  • Electrochemical synthesis of perfluoroalkylfluorophosphanes
    Merck 1037895*

  • Highly active cationic ruthenium and osmium complexes for olefin metathesis reactions
    Studiengesellschaft Kohle 1037897*

  • Secreted proteins
    Genetics Institute 1037898*

  • Peptide based gemini compounds
    SmithKline Beecham 1037903*

  • Branched building units for synthesising cyclic peptides
    Peptor 1037904*

  • Antipicornaviral compounds and methods for their use and preparation
    Agouron Pharmaceuticals 1037905*

  • Cyclopeptide derivatives with integrin inhibitor properties
    Merck 1037906*

  • Bone morphogenetic protein (BMP)-17 and BMP-18 and compsns thereof
    Genetics Institute 1037907*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now